advertisement

Oculus

11.3.3 Apraclonidine, brimonidine (18)

Showing records 1 to 18

Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine

Search within classification 11.3.3 Apraclonidine, brimonidine
84144 Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Emad Eldeeb A
Drug Delivery 2019; 26: 509-521
85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Nitta K
Clinical Ophthalmology 2020; 14: 213-219
85105 Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Wy S
Korean Journal of Ophthalmology 2020; 34: 19-26
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Wang N
Clinical Ophthalmology 2020; 14: 221-230
84144 Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Salah S
Drug Delivery 2019; 26: 509-521
85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Shimamoto S
Clinical Ophthalmology 2020; 14: 213-219
85105 Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Kim YK
Korean Journal of Ophthalmology 2020; 34: 19-26
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Lu DW; Pan Y
Clinical Ophthalmology 2020; 14: 221-230
84144 Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Ghorab M
Drug Delivery 2019; 26: 509-521
85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Wajima R
Clinical Ophthalmology 2020; 14: 213-219
85105 Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Jeoung JW; Park KH
Korean Journal of Ophthalmology 2020; 34: 19-26
85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Tachibana G
Clinical Ophthalmology 2020; 14: 213-219
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Astakhov Y; Iureva T
Clinical Ophthalmology 2020; 14: 221-230
85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Yamada Y
Clinical Ophthalmology 2020; 14: 213-219
85105 Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Ha A
Korean Journal of Ophthalmology 2020; 34: 19-26
85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Domoto M
Clinical Ophthalmology 2020; 14: 213-219
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Adewale A; Walker TM
Clinical Ophthalmology 2020; 14: 221-230
85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Takeda R; Takahashi Y; Sugiyama K
Clinical Ophthalmology 2020; 14: 213-219

Issue 21-1

Select Issue


advertisement

Oculus